Xcout Intel
Ataraxis AI, Inc.
Ataraxis AI is an artificial intelligence company headquartered in New York that links AI model predictions to real patient outcomes across oncology.
Subscribe to see Ataraxis AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ataraxis AI, Inc. at a glance
Ataraxis AI, Inc. is an ai/ml company headquartered in United States, founded in 2022. Its most recent funding round raised $20M in December 2024. Xcout tracks 6 named people at Ataraxis AI, Inc., including Jan Witowski (Chief Executive Officer). Xcout recorded 21 job postings from Ataraxis AI, Inc. in the last 90 days, naming tools such as Hugging Face, OpenAI API, PyTorch.
Ataraxis AI, Inc. leadership
- Jan WitowskiChief Executive Officer
- Jan WitowskiChief Executive Officer & Co-Founder
- Krzysztof GerasChief Scientific Officer & Co-Founder
- Jan WitowskiExecutive Officer
- Krish RamaduralDirector
- Rohan GaneshananthanDirector
Ataraxis AI, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Ataraxis AI, Inc.
Xcout recorded 21 job postings from Ataraxis AI, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
Tools named in Ataraxis AI, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Ataraxis AI, Inc.'s hiring signals →
Tech stack
Ataraxis AI, Inc. competitors
A few of Ataraxis AI, Inc.'s closest competitors — see the full list of competitors and alternatives →
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
Cellyrix Therapeutics is a biotechnology company founded in 2024 and headquartered in Rehovot, Israel. The company leverages single-cell RNA sequencing and artificial intelligence to develop cancer treatments by addressing tumor heterogeneity and cell-state modulation.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
ONCOCROSS Co., Ltd. is a public company headquartered in Seoul, South Korea. The company specializes in AI-driven drug discovery, focusing on making drugs work effectively.
TenAces Biosciences is an Israel-based biopharmaceutical company and AION Labs startup that develops molecular glue therapeutics. The company utilizes machine learning and an AI platform to identify protein interactions and discover new molecular glue therapies.
Get Ataraxis AI, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ataraxis AI, Inc. in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access